Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia

P Bourgeat1, G Chételat, V L Villemagne

  • 1CSIRO Preventative Health National Research Flagship ICTC, The Australian e-Health Research Centre-BioMedIA, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia. pierrick.bourgeat@csiro.au

Neurology
|January 13, 2010
PubMed
Abstract

Insights

Beta-amyloid (Abeta) deposition in the temporal neocortex correlates with hippocampal atrophy in healthy older adults. This suggests early Abeta accumulation may drive neurodegeneration, even before cognitive impairment.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Gerontology

Background:

  • Alzheimer's disease (AD) is characterized by beta-amyloid (Abeta) plaques and neurodegeneration.
  • Hippocampal atrophy is a key feature of AD and mild cognitive impairment (MCI).
  • The relationship between Abeta burden and hippocampal atrophy in early disease stages is not fully understood.

Purpose of the Study:

  • To examine the association between global and regional Abeta burden, measured by 11C-Pittsburgh compound B (PIB) PET, and hippocampal atrophy on MRI.
  • To investigate this relationship in healthy controls (HC), amnestic mild cognitive impairment (aMCI), and AD patients.

Main Methods:

  • 92 HC, 32 aMCI, and 35 AD participants underwent 11C-PIB PET and MRI scans.
  • Hippocampal volume was measured, and PIB standardized uptake value ratio (SUVR) was extracted from 41 regions of interest after partial volume correction.
  • Region-based and voxel-based correlations between PIB SUVR and hippocampal volume were computed for each group.

Main Results:

  • A significant correlation between PIB retention in the inferior temporal region and hippocampal volume was observed in HC with elevated neocortical PIB retention.
  • This correlation was found using both region-based and voxel-based analyses.
  • No significant correlation was found in the aMCI or AD groups.

Conclusions:

  • In PIB-positive healthy controls, Abeta deposition in the inferior temporal neocortex is strongly associated with hippocampal atrophy.
  • This finding suggests that Abeta accumulation in specific neocortical regions may initiate hippocampal synaptic and neuronal degeneration.
  • These early pathological changes may precede the development of MCI or AD.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...